Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY22.00 CNY
Change Today +0.47 / 2.18%
Volume 20.0M
As of 3:00 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for xizang haisco pharmaceutic-a (002653)

Year over year, Xizang Haisco Pharmaceutical Group Co., Ltd. has seen their bottom line shrink from CNY519.2M CNY to CNY450.5M CNY despite an increase in revenues from CNY986.7M CNY to CNY1.2B CNY. An increase in the percentage of sales devoted to SGA costs from 29.12% to 35.95% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
Restated
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues603.7799.3986.71,210.6
Other Revenues0.82.85.70.0
TOTAL REVENUES604.4802.1992.31,210.6
Cost of Goods Sold200.9204.3268.7366.9
GROSS PROFIT403.5597.8723.6843.6
Selling General & Admin Expenses, Total112.9265.9287.3435.2
Other Operating Expenses9.710.919.621.5
OTHER OPERATING EXPENSES, TOTAL122.6276.8307.0456.6
OPERATING INCOME280.9321.0416.7387.0
Interest Expense-0.1-0.7-3.4-11.6
Interest and Investment Income6.628.948.179.3
NET INTEREST EXPENSE6.528.244.767.7
Currency Exchange Gains (Loss)0.0-0.3--0.0
Other Non-Operating Income (Expenses)-0.1---0.1-0.1
EBT, EXCLUDING UNUSUAL ITEMS287.4348.8461.3454.5
Gain (Loss) on Sale of Assets-1.0-3.4-2.8-0.2
Other Unusual Items, Total83.1134.9110.450.2
Other Unusual Items83.1134.9110.450.2
EBT, INCLUDING UNUSUAL ITEMS369.4480.3568.8504.5
Income Tax Expense57.137.349.654.0
Earnings from Continuing Operations312.3443.1519.2450.5
NET INCOME312.3443.1519.2450.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS312.3443.1519.2450.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS312.3443.1519.2450.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY22.00 CNY +0.47

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 50.2x
Price/Sales 19.4x
Price/Book 10.8x
Price/Cash Flow 49.6x
TEV/Sales 17.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.